BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3815587)

  • 1. DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide.
    Hemminki K
    Chem Biol Interact; 1987 Jan; 61(1):75-88. PubMed ID: 3815587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K
    Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(2-hydroxyethyl)-N-[2-(7-guaninyl)ethyl]amine, the putative major DNA adduct of cyclophosphamide in vitro and in vivo in the rat.
    Benson AJ; Martin CN; Garner RC
    Biochem Pharmacol; 1988 Aug; 37(15):2979-85. PubMed ID: 3395373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of hydrolysis in vitro of nornitrogen mustard, a metabolite of phosphoramide mustard and cyclophosphamide.
    Hemminki K; Alhonen A; Linkola E; Hesso A
    Arch Toxicol; 1987 Dec; 61(2):126-30. PubMed ID: 3439884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilities of 7-alkylguanosines and 7-deoxyguanosines formed by phosphoramide mustard and nitrogen mustard.
    Kallama S; Hemminki K
    Chem Biol Interact; 1986 Jan; 57(1):85-96. PubMed ID: 3948286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxazolidonylethyl adducts to hemoglobin and DNA following nornitrogen mustard exposure.
    Thulin H; Zorcec V; Segerbäck D; Sundwall A; Törnqvist M
    Chem Biol Interact; 1996 Jan; 99(1-3):263-75. PubMed ID: 8620574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of phosphoramide mustard/DNA adducts using tandem mass spectrometry.
    Cushnir JR; Naylor S; Lamb JH; Farmer PB; Brown NA; Mirkes PE
    Rapid Commun Mass Spectrom; 1990 Oct; 4(10):410-4. PubMed ID: 2134189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkylating properties of phosphoramide mustard.
    Colvin M; Brundrett RB; Kan MN; Jardine I; Fenselau C
    Cancer Res; 1976 Mar; 36(3):1121-6. PubMed ID: 1253171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nitrogen mustard formamidopyrimidine adduct formation of bis(2-chloroethyl)ethylamine with calf thymus DNA and a human mammary cancer cell line.
    Gruppi F; Hejazi L; Christov PP; Krishnamachari S; Turesky RJ; Rizzo CJ
    Chem Res Toxicol; 2015 Sep; 28(9):1850-60. PubMed ID: 26285869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative high-performance liquid chromatography-electrospray ionization tandem mass spectrometry analysis of bis-N7-guanine DNA-DNA cross-links in white blood cells of cancer patients receiving cyclophosphamide therapy.
    Malayappan B; Johnson L; Nie B; Panchal D; Matter B; Jacobson P; Tretyakova N
    Anal Chem; 2010 May; 82(9):3650-8. PubMed ID: 20361772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent DNA-Protein Cross-Linking by Phosphoramide Mustard and Nornitrogen Mustard in Human Cells.
    Groehler A; Villalta PW; Campbell C; Tretyakova N
    Chem Res Toxicol; 2016 Feb; 29(2):190-202. PubMed ID: 26692166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis and excision of ring-opened phosphoramide mustard-deoxyguanine adducts in DNA.
    Chetsanga CJ; Polidori G; Mainwaring M
    Cancer Res; 1982 Jul; 42(7):2616-21. PubMed ID: 7083154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
    Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
    Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylation of guanosine and deoxyguanosine by phosphoramide mustard.
    Mehta JR; Przybylski M; Ludlum DB
    Cancer Res; 1980 Nov; 40(11):4183-6. PubMed ID: 7471059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of phosphoramide mustard hydrolysis in aqueous solution.
    Watson E; Dea P; Chan KK
    J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
    Maccubbin AE; Caballes L; Chheda GB; Struck RF; Gurtoo HL
    Biochem Biophys Res Commun; 1989 Sep; 163(2):843-50. PubMed ID: 2783126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5815-20. PubMed ID: 6640533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas chromatographic-mass spectrometric assay for N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in rat plasma.
    Lu H; Chan KK
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):219-25. PubMed ID: 8738025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic determination of N-[2-(hydroxyethyl)-N-(2-(7-guaninyl)ethyl)]methylamine, a reaction product between nitrogen mustard and DNA and its application to biological samples.
    Sperry ML; Skanchy D; Marino MT
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):187-93. PubMed ID: 9824232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.